BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19307502)

  • 21. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extra-osseous Ewing sarcoma.
    van den Berg H; Heinen RC; van der Pal HJ; Merks JH
    Pediatr Hematol Oncol; 2009 Jun; 26(4):175-85. PubMed ID: 19437320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma.
    Szuhai K; IJszenga M; Tanke HJ; Taminiau AH; de Schepper A; van Duinen SG; Rosenberg C; Hogendoorn PC
    Cancer Genet Cytogenet; 2007 Jan; 172(1):12-22. PubMed ID: 17175374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review.
    Maire G; Brown CW; Bayani J; Pereira C; Gravel DH; Bell JC; Zielenska M; Squire JA
    Cancer Genet Cytogenet; 2008 Mar; 181(2):81-92. PubMed ID: 18295659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.
    Pasello M; Manara MC; Michelacci F; Fanelli M; Hattinger CM; Nicoletti G; Landuzzi L; Lollini PL; Caccuri A; Picci P; Scotlandi K; Serra M
    Anal Cell Pathol (Amst); 2011; 34(3):131-45. PubMed ID: 21673434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular abnormalities in Ewing's sarcoma.
    Burchill SA
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1675-87. PubMed ID: 18925858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo study.
    Martins AS; Ordoñez JL; García-Sánchez A; Herrero D; Sevillano V; Osuna D; Mackintosh C; Caballero G; Otero AP; Poremba C; Madoz-Gúrpide J; de Alava E
    Cancer Res; 2008 Aug; 68(15):6260-70. PubMed ID: 18676850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
    Lanvers-Kaminsky C; Bremer A; Dirksen U; Jürgens H; Boos J
    Anticancer Drugs; 2006 Jul; 17(6):657-62. PubMed ID: 16917211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
    Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
    J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procholecystokinin as marker of human Ewing sarcomas.
    Reubi JC; Koefoed P; Hansen Tv; Stauffer E; Rauch D; Nielsen FC; Rehfeld JF
    Clin Cancer Res; 2004 Aug; 10(16):5523-30. PubMed ID: 15328192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short telomeres: a novel potential predictor of relapse in Ewing sarcoma.
    Avigad S; Naumov I; Ohali A; Jeison M; Berco GH; Mardoukh J; Stark B; Ash S; Cohen IJ; Meller I; Kollender Y; Issakov J; Yaniv I
    Clin Cancer Res; 2007 Oct; 13(19):5777-83. PubMed ID: 17908968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma.
    Ferreira BI; Alonso J; Carrillo J; Acquadro F; Largo C; Suela J; Teixeira MR; Cerveira N; Molares A; Goméz-López G; Pestaña A; Sastre A; Garcia-Miguel P; Cigudosa JC
    Oncogene; 2008 Mar; 27(14):2084-90. PubMed ID: 17952124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-weighted imaging as predictor of therapy response in an animal model of Ewing sarcoma.
    Reichardt W; Juettner E; Uhl M; Elverfeldt DV; Kontny U
    Invest Radiol; 2009 May; 44(5):298-303. PubMed ID: 19346963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SK-NEP-1 and Rh1 are Ewing family tumor lines.
    Smith MA; Morton CL; Phelps D; Girtman K; Neale G; Houghton PJ
    Pediatr Blood Cancer; 2008 Mar; 50(3):703-6. PubMed ID: 17154184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies.
    Rodríguez-Galindo C; Liu T; Krasin MJ; Wu J; Billups CA; Daw NC; Spunt SL; Rao BN; Santana VM; Navid F
    Cancer; 2007 Jul; 110(2):375-84. PubMed ID: 17569105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma.
    Avigad S; Shukla S; Naumov I; Cohen IJ; Ash S; Meller I; Kollender Y; Issakov J; Yaniv I
    Pediatr Blood Cancer; 2009 Dec; 53(6):1023-8. PubMed ID: 19637319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate.
    Efferth T; Volm M
    In Vivo; 2005; 19(1):225-32. PubMed ID: 15796179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
    Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M
    Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumours.
    Luksch R; Grignani G; Fagioli F; Brach del Prever A; Podda M; Aliberti S; Casanova M; Prete A; Hanau G; Tamburini A; Allione P; Tienghi A; Ferrari S; Collini P; Marchianò A; Gandola L; Aglietta M; Madon E; Picci P; Fossati-Bellani F
    Eur J Cancer; 2007 Mar; 43(5):885-90. PubMed ID: 17254770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
    Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
    Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.